WATCH: AACI Hereditary Cancer Webinar Series
The Association of American Cancer Institutes' Physician Clinical Leadership Initiative (PCLI) presented a two-part webinar series on hereditary cancer programs and cancer risk assessment.
The first webinar focused on models of testing for pancreatic, breast, ovarian, and prostate cancers. It was held on Wednesday, October 2, at 11:00 a.m.
This webinar was presented by Marie Wood, MD, and Wendy McKinnon, MS. Wood, a professor of medicine at the University of Vermont, is the founder and principal investigator of the High Risk Breast Program (HRBP) at the University of Vermont Cancer Center where she's a medical oncologist. McKinnon is a cancer genetics counselor at the University of Vermont Cancer Center and a clinical assistant professor at the University of Vermont.
ICYMI: Read the Recap
Slides/Video
The second webinar of the series highlighted models of testing for colon and hematologic cancers and informed consent. It was held on Wednesday, November 13, at 11:00 a.m.
This webinar was presented by Joanne Jeter, MD, oncologist and associate professor of medicine, and Heather Hampel, MS, LGC, associate director of the division of human genetics — both from The Ohio State University Comprehensive Cancer Center, James Cancer Hospital & Solove Research Institute.